All News

    Venclexta Treatment Combo is Being Reviewed by FDA For CLL

    July 30th 2025, 9:00pm

    Article

    AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic lymphocytic leukemia.

    July Lung Cancer Highlights: Top 5 Updates Patients Should Know

    July 30th 2025, 8:00pm

    Article

    As July concludes, momentum in lung cancer research continues to build, marked by FDA decisions, trial progress, and patient-centered perspectives.

    Jaypirca Shows Improvements Over Imbruvica in CLL/SLL

    July 30th 2025, 7:00pm

    Article

    Jaypirca led to better response rates than Imbruvica in some previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

    July Blood Cancer Highlights: Top 5 Updates Patients Should Know

    July 30th 2025, 5:00pm

    Article

    As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, myelofibrosis, and CLL.

    Building My Medical Team and Support System After a Cancer Diagnosis

    July 30th 2025, 4:00pm

    Article

    After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.

    FDA Grants Orphan Drug Status to VT3989 for Mesothelioma Treatment

    July 30th 2025, 3:00pm

    Article

    The FDA awarded orphan drug designation to VT3989 for mesothelioma, supporting the experimental cancer treatment’s development.

    Making Cancer Clinical Trials More Accessible in Local Communities

    July 30th 2025, 1:00pm

    Video

    Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.

    My Cancer Passion: Writing It Down

    July 29th 2025, 9:00pm

    Article

    When my daughter was diagnosed with breast cancer, writing our truth helped me and others face the harsh realities and lasting impact of cancer survivorship.

    The Leukemia & Lymphoma Society Unveils Name Change to Reach All Blood Cancer Patients

    July 29th 2025, 8:50pm

    Article

    The Leukemia & Lymphoma Society, a nonprofit in funding blood cancer research, patient support and advocacy, is becoming Blood Cancer United on August 28.

    Some Pediatric Cancer Treatments Tied to Faster Aging in Survivors

    July 29th 2025, 8:00pm

    Video

    Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.